FOXP3 and breast cancer: Methylation at various CpG present in the upstream promoter area of FOXP3 gene was observed in 73 cases (73/140, 52.14%) (Figure 3) and, once linked with clinical parameters, revealed a significant association with the Nottingham histological grades 1 and 2 type tumors of breast cancer patients (0.031).